• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺特异性抗原(PSA)水平及年龄特异性PSA参考范围在中国检测前列腺癌中的临床实用性。

The clinical usefulness of prostate-specific antigen (PSA) level and age-specific PSA reference ranges for detecting prostate cancer in Chinese.

作者信息

Wu Tony T, Huang Jong-Khing

机构信息

Division of Urology, Kaohsiung Veterans General Hospital, and Yang-Ming University, School of Medicine, Taipei, Taiwan, ROC.

出版信息

Urol Int. 2004;72(3):208-11. doi: 10.1159/000077116.

DOI:10.1159/000077116
PMID:15084763
Abstract

INTRODUCTION

To determine the role of prostate-specific antigen (PSA) level and age-specific PSA reference ranges for detecting prostate cancer in Chinese.

MATERIAL AND METHODS

We retrospectively reviewed the medical records of all 50- to 79-year-old men who had their first-time prostatic biopsy done at our institute between January 1998 and December 2000. We evaluated the effect on biopsy rate and cancer detection if the PSA cutoff was shifted from 4.0 ng/ml to the age-specific reference ranges. Also, we tried to develop age-adjusted PSA cutoffs for Chinese.

RESULTS

Among 1,236 men enrolled, 252 (20.4%) were diagnosed as prostate cancers. The positive predictive value was 22.2% for PSA >4.0 ng/ml. Using the traditional age-specific PSA reference ranges 134 (10.8%) biopsies could be avoided but five (1.98%) cancers would be missed. We proposed age-specific PSA reference ranges for Chinese as: 0-4.0 ng/ml for men in their 50s and 0-6.0 ng/ml for men between 60 and 79 years. Had we used these alternative cutoffs, 150 (12.1%) biopsies could be saved, of them 3 were cancers.

CONCLUSIONS

The age-specific PSA reference ranges may help to avoid 12% of biopsies but 1.2% of prostate cancers would have gone undetected. Among population with low incidence of prostate cancer as Chinese, minimizing unnecessary biopsies might be more important issue than maximizing cancer detection rate.

摘要

引言

确定前列腺特异性抗原(PSA)水平及年龄特异性PSA参考范围在中国前列腺癌检测中的作用。

材料与方法

我们回顾性分析了1998年1月至2000年12月期间在我院首次接受前列腺活检的所有50至79岁男性的病历。我们评估了如果将PSA临界值从4.0 ng/ml调整为年龄特异性参考范围对活检率和癌症检测的影响。此外,我们试图为中国人制定年龄调整后的PSA临界值。

结果

在纳入的1236名男性中,252人(20.4%)被诊断为前列腺癌。PSA>4.0 ng/ml时的阳性预测值为22.2%。使用传统的年龄特异性PSA参考范围可避免134例(10.8%)活检,但会漏诊5例(1.98%)癌症。我们提出中国人的年龄特异性PSA参考范围为:50多岁男性为0 - 4.0 ng/ml,60至79岁男性为0 - 6.0 ng/ml。如果使用这些替代临界值,可节省150例(12.1%)活检,其中3例为癌症。

结论

年龄特异性PSA参考范围可能有助于避免12%的活检,但会有1.2%的前列腺癌未被检测到。在前列腺癌发病率较低的中国人群中,尽量减少不必要的活检可能比提高癌症检测率更重要。

相似文献

1
The clinical usefulness of prostate-specific antigen (PSA) level and age-specific PSA reference ranges for detecting prostate cancer in Chinese.前列腺特异性抗原(PSA)水平及年龄特异性PSA参考范围在中国检测前列腺癌中的临床实用性。
Urol Int. 2004;72(3):208-11. doi: 10.1159/000077116.
2
Standard versus age-specific prostate specific antigen reference ranges among men with clinically localized prostate cancer: A pathological analysis.临床局限性前列腺癌男性中标准与年龄特异性前列腺特异性抗原参考范围:一项病理分析。
J Urol. 1996 Apr;155(4):1336-9.
3
Comparison of different prostate-specific antigen cutpoints for early detection of prostate cancer: results of a large screening study.不同前列腺特异性抗原切点用于前列腺癌早期检测的比较:一项大型筛查研究的结果
Urology. 1995 Nov;46(5):662-5. doi: 10.1016/S0090-4295(99)80297-0.
4
Are age-specific reference ranges for prostate specific antigen population specific?前列腺特异性抗原的年龄特异性参考范围是否因人群而异?
Anticancer Res. 2000 Nov-Dec;20(6D):4981-3.
5
Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. range.在总前列腺特异性抗原水平为2至4纳克/毫升范围内的游离前列腺特异性抗原百分比,与4至10纳克/毫升范围内相比,并不会显著增加检测临床显著性前列腺癌所需的活检次数。
J Urol. 2002 Aug;168(2):504-8.
6
Rationale for using serum prostate-specific antigen (PSA) level and PSA density (PSAD) to detect prostatic malignancy in a country with low prostate cancer incidence.在一个前列腺癌发病率较低的国家,使用血清前列腺特异性抗原(PSA)水平和PSA密度(PSAD)检测前列腺恶性肿瘤的原理。
Gan To Kagaku Ryoho. 2000 May;27 Suppl 2:563-70.
7
[The detection rate of prostate cancer in different prostate-specific antigen (PSA) levels in Chinese men].[中国男性不同前列腺特异性抗原(PSA)水平下前列腺癌的检出率]
Zhonghua Yi Xue Za Zhi. 2008 Jan 1;88(1):16-8.
8
[Clinical value of prostate specific antigen screening in early detection of prostate cancer].前列腺特异性抗原筛查在前列腺癌早期检测中的临床价值
Zhonghua Zhong Liu Za Zhi. 2009 Sep;31(9):705-9.
9
Significance of serum free prostate specific antigen in the screening of prostate cancer.血清游离前列腺特异性抗原在前列腺癌筛查中的意义
J Urol. 1996 Dec;156(6):1964-8.
10
Serum prostate-specific antigen in healthy Chinese men: establishment of age-specific reference ranges.健康中国男性的血清前列腺特异性抗原:特定年龄参考范围的建立
Neoplasma. 1996;43(2):103-5.

引用本文的文献

1
Correlation between periodontitis and prostate-specific antigen levels in the elderly Chinese male population.牙周炎与老年中国男性人群前列腺特异性抗原水平的相关性。
BMC Oral Health. 2022 May 6;22(1):163. doi: 10.1186/s12903-022-02171-9.
2
The influence of age on prostate cancer screening index.年龄对前列腺癌筛查指数的影响。
J Clin Lab Anal. 2022 Jan;36(1):e24098. doi: 10.1002/jcla.24098. Epub 2021 Nov 24.
3
Improving the detection rate of prostate cancer in the gray zone of PI-RADS v2 and serum tPSA by using prostate-specific antigen-age volume.
利用前列腺特异性抗原-年龄体积提高PI-RADS v2灰色区域及血清总前列腺特异性抗原中前列腺癌的检出率。
Medicine (Baltimore). 2019 Jun;98(26):e16289. doi: 10.1097/MD.0000000000016289.
4
Prostate cancer in Asia: A collaborative report.亚洲的前列腺癌:一份合作报告。
Asian J Urol. 2014 Oct;1(1):15-29. doi: 10.1016/j.ajur.2014.08.007. Epub 2015 Apr 16.
5
Anticancer effect of deoxypodophyllotoxin induces apoptosis of human prostate cancer cells.脱氧鬼臼毒素的抗癌作用诱导人前列腺癌细胞凋亡。
Oncol Lett. 2016 Oct;12(4):2918-2923. doi: 10.3892/ol.2016.4943. Epub 2016 Aug 3.
6
Prostate cancer in East Asia: evolving trend over the last decade.东亚地区的前列腺癌:过去十年的演变趋势
Asian J Androl. 2015 Jan-Feb;17(1):48-57. doi: 10.4103/1008-682X.132780.
7
Prostate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancer.疑似前列腺癌的印度尼西亚人群中前列腺特异性抗原和前列腺特异性抗原密度的截断值。
Prostate Int. 2013;1(1):23-30. doi: 10.12954/PI.12003. Epub 2013 Jan 31.
8
External validation of the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer risk calculators in a Chinese cohort.在中国队列中对前列腺癌预防试验和欧洲前列腺癌筛查风险计算器随机研究的风险计算器进行外部验证。
Asian J Androl. 2012 Sep;14(5):738-44. doi: 10.1038/aja.2012.28. Epub 2012 May 7.
9
The value of prostate-specific antigen in Asia.亚洲前列腺特异性抗原的价值。
Ther Adv Urol. 2010 Apr;2(2):77-83. doi: 10.1177/1756287210370329.